640 related articles for article (PubMed ID: 30001869)
1. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention.
Shimizu T; Suwa S; Dohi T; Wada H; Miyauchi K; Shitara J; Endo H; Doi S; Ogita M; Kasai T; Okazaki S; Isoda K; Daida H
Int Heart J; 2019 Sep; 60(5):1037-1042. PubMed ID: 31484863
[TBL] [Abstract][Full Text] [Related]
3. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
4. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
6. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Endo H; Dohi T; Funamizu T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Shimada K; Miyauchi K; Daida H
Circ J; 2019 Feb; 83(3):630-636. PubMed ID: 30541988
[TBL] [Abstract][Full Text] [Related]
8. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
Liu Y; Jia SD; Yao Y; Tang XF; Xu N; Jiang L; Gao Z; Chen J; Yang YJ; Gao RL; Xu B; Yuan JQ
J Cardiol; 2020 Jan; 75(1):60-65. PubMed ID: 31416781
[TBL] [Abstract][Full Text] [Related]
9. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level.
Wada H; Dohi T; Miyauchi K; Nishio R; Takeuchi M; Takahashi N; Endo H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Int Heart J; 2020 May; 61(3):447-453. PubMed ID: 32418963
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
[TBL] [Abstract][Full Text] [Related]
12. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
[TBL] [Abstract][Full Text] [Related]
14. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
[TBL] [Abstract][Full Text] [Related]
16. Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI.
Dai XY; Zheng YY; Tang JN; Wang W; Guo QQ; Yin SS; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34121126
[TBL] [Abstract][Full Text] [Related]
17. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.
Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y
BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476
[TBL] [Abstract][Full Text] [Related]
18. Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention.
Suwa S; Ogita M; Takahashi N; Wada H; Dohi T; Kasai T; Okazaki S; Shimada K; Miyauchi K; Bujo H; Daida H
Int Heart J; 2020 May; 61(3):470-475. PubMed ID: 32350212
[TBL] [Abstract][Full Text] [Related]
19. Impact of preprocedural high-sensitive C-reactive protein levels on long-term clinical outcomes of patients with stable coronary artery disease and chronic kidney disease who were treated with drug-eluting stents.
Ogita M; Miyauchi K; Kasai T; Doi S; Wada H; Naito R; Konishi H; Tsuboi S; Dohi T; Tamura H; Okazaki S; Daida H
J Cardiol; 2015 Jul; 66(1):15-21. PubMed ID: 25572020
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
